Scoparia dulcis, a traditional antidiabetic plant, protects against streptozotocin induced oxidative stress and apoptosis in vitro and in vivo

Journal of Biochemical and Molecular Toxicology

Volumn 18, Issue 5, 2004, Pages 261-272

  Latha, Muniappan ^a   Pari, Leelavinothan ^a   Sitasawad, Sandhya ^b   Bhonde, Ramesh ^b  

^a ANNAMALAI UNIVERSITY   (India)

^b NATIONAL CENTRE FOR CELL SCIENCE   (India)

Author keywords

Apoptosis; Islets of Langerhans; Lipidperoxidation; Oxidative Stress; RINm5F Cells; Scoparia dulcis

Indexed keywords

ANTIDIABETIC AGENT; CATALASE; DICHLOROFLUORESCEIN; FLUORESCENT DYE; GLUCOSE; GLUTATHIONE; HERBACEOUS AGENT; INSULIN; LIPID; NITRIC OXIDE; PANCREAS ENZYME; PLANT EXTRACT; SCOPARIA DULCIS EXTRACT; SUPEROXIDE DISMUTASE; THIOBARBITURIC ACID REACTIVE SUBSTANCE; UNCLASSIFIED DRUG;

ADOLESCENT; ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ANTIHYPERGLYCEMIC EFFECT; ANTIOXIDANT ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL PROTECTION; CELL STRAIN RINM5F; CONTROLLED STUDY; CYTOTOXICITY; DIABETES MELLITUS; DRUG EFFECT; DRUG MECHANISM; FLOW CYTOMETRY; GLUCOSE BLOOD LEVEL; HORMONE ACTION; IN VITRO STUDY; IN VIVO STUDY; INSULIN RELEASE; INSULINOMA; LIPID PEROXIDATION; MALE; MEDICINAL PLANT; NONHUMAN; OXIDATIVE STRESS; PANCREAS ISLET; PANCREAS ISLET BETA CELL; RAT; SCOPARIA; SCOPARIA DULCIS; TRADITIONAL MEDICINE;

ANIMALS; APOPTOSIS; BLOOD GLUCOSE; CATALASE; CELL LINE, TUMOR; DIABETES MELLITUS, EXPERIMENTAL; INSULIN; INSULINOMA; ISLETS OF LANGERHANS; LIPID PEROXIDATION; MALE; OXIDATIVE STRESS; PANCREATIC NEOPLASMS; PHYTOTHERAPY; PLANT EXTRACTS; RATS; RATS, WISTAR; SCOPARIA; STREPTOZOCIN; SUPEROXIDE DISMUTASE; THIOBARBITURIC ACID REACTIVE SUBSTANCES;

FELIS CATUS; RATTUS NORVEGICUS; SCOPARIA; SCOPARIA DULCIS;

EID: 7744223453     PISSN: 10956670     EISSN: None     Source Type: Journal    
DOI: 10.1002/jbt.20035     Document Type: Article

References (56)

1. Halliwell B, Gutteridge JMG. Free radicals in biology and medicine 2nd edition. Oxford: Clarendon; 1989.
2. Baynes JW. Role of oxidative stress in the development of complications in diabetes. Diabetes 1991;40:405-412.
3. Schmezer P, Eckert C, Liegibel UM. Tissue specific induction of mutation by streptozotocin in vivo. Mut Res 1994;307:495-499.
4. Ohkuwa T, Sato Y, Naoi M. Hydroxyl radical formation in diabetic rats induced by streptozotocin. Life Sci 1995;56:1789-1796.
5. Ivorra MD, Paya M, Villar A. A review of natural products and plants as potential antidiabetic drugs. J Ethnopharmacol 1989;27:243-245.
6. Lukic ML, Stostic-Grujicic S, Shahin A. Effector mechanisms in low dose streptozotocin induced diabetes. Dev Immunol 1998;6:119-128.
7. Spinas GA. The dual role of nitric oxide in islet β-cells. News Phy Sci 1999;14:49-54.
8. Kannan K, Jain SK. Oxidative stress and apoptosis. Pathophysiology 2000;7:153-163.
9. O'Brien BA, Harmon BV, Cameron DP, Allan DJ. Apoptosis is the mode of β-cell death responsible for the development of IDDM in the nonobese diabetic (NOD) mouse. Diabetes 1997;46:750-757.
10. Thompson CB. Apoptosis in the pathogenesis and treatment of disease. Science 1995;267:1456-1462.
11. Bolzan AD, Bianchi MS. Genotoxicity of streptozotocin. Mut Res 2002;512:121-134.
12. Chandra J, Samali A, Orrenius S. Triggering and modulation of apoptosis by oxidative stress. Free Radical Biol Med 2000;29:323-333.
13. Murata M, Takahashi A, Saito I, kawanishi S. Site specific DNA methylation and apoptosis: Induction by diabetogenic streptozotocin. Biochem Pharmacol 1999;57:881-887.
14. Brown GC, Borutaite V. Nitric oxide, mitochondria and cell death. IUBMB Life 2001;52:189-195.
15. Kaneto H, Fuji J, Seo HG, Suzuki K, Matsoka T, Nakamura M, Tatsumi H, Yamamsaki Y, Kamada T, Taniguchi N. Apoptotic cell death triggered by nitric oxide in pancreatic β-cells. Diabetes 1995;44:733-738.
16. McGowan AJ, Fernandez RJ, Samali A, Cotter TG. Antioxidants and apoptosis. Biochem Soc Trans 1996;24:229-233.
17. Strain JJ. Disturbances of micronutrient and antioxidant status in diabetes. Proc Nutr Soc 1991;50:591-604.
18. Mclennan SV, Heffenen S, Wright L. Changes in hepatic glutathione metabolism in diabetes. Diabetes 1991;40:344-348.
19. Kinloch RM, Treherne JM, Furness LM, Hajimohamadreza J. The pharmacology of apoptosis. Trends Pharm Sci 1999;20:35-42.
20. Satyanarayana K. Chemical examination of Scoparia dulcis (Linn): Part I. J Indian Chem Soc 1969;46:765-766.
21. Chow SY, Chen SM, Yang CM, Hsu H. Pharmacological studies on China herbs. (I) Hypotensive effect of 30 Chinese herbs. J Form Med Assoc 1974;73:729-739.
22. Nath MC. Investigations on the new antidiabetic principle (amellin) occurring in nature. Part I: Studies on some of its biochemical properties. Ann Biochem Exp Med 1943;3:55-62.
23. Freire SMF, Emim AJS, Lapa AJ, Souccar C, Torres LMB. Analgesic and anti-inflammatory properties of Scoparia dulcis L. extract and glutinol in rodents. Phytother Res 1993;7:408-414.
24. Hayashi T, Okamura K, Tamada Y, Iida A, Fujita T, Morita N. A new chemotype of Scoparia dulcis. Phytochemistry 1993;33:349-352.
25. + - ATPase from Scoparia dulcis and its structure activity relationships. J Nat Prod 1991;54:802-809.
26. Hayashi T, Kawasaki M, Miwa Y, Taga T, Morita N. Antiviral agents of plant origin III. Scopadulin, a novel tetracyclic diterpene from Scoparia dulcis L. Chem Pharm Bull 1990;38:945-947.
27. Latha M, Pari L. Modulatory effect of Scoparia dulcis in oxidative stress-induced lipidperoxidation in streptozotocin diabetic rats. J Med Food 2003;6(4):379-386.
28. Jain SR. Hypoglycaemic principle in the Musa sapientum and its isolation. Planta Med 1968;1:43-47.
29. Siddique O, Sun Y, Lin JC, Chien YW. Facilitated transdermal transport of insulin. J Pharm Sci 1987;76:341-345.
30. Sasaki T, Masty S, Sonae A. Effect of acetic acid concentration on the colour reaction in the O-toluidine boric acid method for blood glucose estimation. Rinshbo kagaku 1972;1:346-353.
31. Niehius WG, Samuelsson D. Formation of Malodialdehyde from phospholipids arachidonate during microsomal lipidperoxidation. Eur J Biochem 1968;6:126-130.
32. Sinha KA. Colorimetric assay of catalase. Anal Biochem 1972;47:389-394.
33. Kakkar P, Das B, Viswanathan PN. A modified spectrophotometric assay of Superoxide dismutase. Indian J Biochem Biophys 1984;21:130-132.
34. Ellman GL. Tissue sulfhydryl groups. Arch Biochem Biophys 1959;82:70-77.
35. Lowry OH, Roesborough MJ, Parr AL, Randall RJ. Protein measurement with Folin-Phenol reagent. J Biol Chem 1951;193:265-275.
36. Shewade YM, Umrani M, Bhonde RR. Large-scale isolation of islets by tissue culture of adult mouse pancreas. Transplant Proc 1999;31:1721-1723.
37. Plumb JA, Milroy R, Kaye SB. Effects of the pH dependence of 3-(4,5-dimethylthiazole-2-yl)-2,5-diphenyl-tetrazoliumbromide-formazan) absorption on chemo sensitivity determined by a novel tetrazolium-based assay. Cancer Res 1989;49:4435-4440.
38. Ignarro LJ, Buga GM, Wood KS, Byrns RE, Chaushury G. Endothelium derived relaxing factor produced and released from artery and vein is nitric oxide. Proc Natl Acad Sci USA 1987;84:9265-9269.
39. Konings WT, Drijver EB. Radiation effects on membranes I: Vitamin E deficiency and lipidperoxidation. Radiat Res 1979;80:494.
40. Kuo WY, Tang TK. Effect of G6PD over expression in NIH3T3 cells treated with tertbutyl hydroperoxide or paraquat. Free Radical Biol Med 1998;24:1130-1138.
41. Dietch AD, Law H, White RD. A stable propidium iodide staining procedure for flow cytometry. J Histochem Cytochem 1982;30:967-972.
42. Sandhya SL, Shewade Y, Bhonde R. Role of Bittergourd fruit juice in STZ-induced diabetic state in vivo and in vitro. J Ethnopharmacol 2000;73:71-79.
43. Latha M, Pari L. Effect of an aqueous extract of Scoparia dulcis on blood glucose, plasma insulin and some polyol pathway enzymes in experimental rat diabetes. Braz J Med Biol Res 2004;37:577-586.
44. Pari L, Latha M. Effect of Scoparia dulcis (sweet broomweed) plant extract on plasma antioxidants in streptozotocin-induced experimental diabetes in male albino Wistar rats. Die Pharmazie 2004;59(7):557-560.
45. Halliwell B, Chirico S. Lipidperoxidation: Its mechanisms, measurements, and significance. Am J Clin Nutr 1993;57:715S-725S.
46. Kono Y, Fridovich I. Inactivation of glutathione peroxidase by superoxide radicals. Arch Biochem Biophys 1985;240:500-508.
47. Spinas GA. The dual role of nitric oxide in islet β-cells. New Physiol Sci 1999;14:49-54.
48. Kolb H, Kolb-Bachofen V. Nitric oxide: A pathogenetic factor in autoimmunity. Immunol Today 1992;13:157-160.
49. Moncada S, Palmer RMJ, Higgs EA. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev 1991;43:109-142.
50. Corbett JA, McDaniel ML. Does nitric oxide mediate autoimmune destruction of β-cells? Possible therapeutic interventions in IDDM. Diabetes 1992;41:897-903.
51. Raza H, Ahmed I, John A, Sharma AK. Modulation of xenobiotic metabolism and oxidative stress in chronic streptozotocin induced diabetic rats fed with Momoridca charantia fruit extract. J Biochem Mol Toxicol. 2000;3:131-139.
52. Feillet-Coudray C, Rock E, Coudray C, Grzelkowska K, Azais-Braesco V, Dardevet D, Mazur A. Lipidperoxidation and antioxidant status in experimental diabetes. Clin Chim Acta 1999;284:31-43.
53. Saini KS, Thompson C, Winerford CM, Walker NI, Cameron DP. Streptozotocin at low doses induces apoptosis and at high doses causes necrosis in a murine pancreatic beta cell line, INS-1. Biochem Mol Biol Int 1996;39:1229-1236.
54. Hockenbery MD, Oltvai Z, Xiao-Ming Y, Milliman LC, Korsmeyer JS. Bcl-2 functions in an antioxidant pathway to prevent apoptosis. Cell 1993;75:241-251.
55. Monette R, Small DL, Mealing G, Morely P. A fluorescence confocal assay to assess neuronal viability in brain slices. Brain Res Protocol 1998;2:99-108.
56. Macklis JD, Madison RD. Progressive incorporation of propidium iodide in cultured mouse neurons correlates with declining electrophysiological status: A fluorescence scale of membrane integrity. J Neurosci Methods 1990;31:43-46.